Comment
Author: Admin | 2025-04-28
Evaluating effectiveness of postcoital contraception". Contraception. 60 (4): 243–247. doi:10.1016/S0010-7824(99)00090-6. PMID 10640171.^ Kuchera LK (October 1971). "Postcoital contraception with diethylstilbestrol". JAMA. 218 (4): 562–563. doi:10.1001/jama.218.4.562. PMID 5171004.^ FDA (August 1973). "Selected items from the FDA drug bulletin-may 1973". California Medicine. 119 (2): 87–88. PMC 1455105. PMID 18730987.^ a b c U.S. Senate (1975). Regulation of diethylstilbestrol (DES), 1975: Joint Hearing before the Subcommittee on Health and the Subcommittee on Administrative Practice and Procedure, 94th Congress, 1st Session on S. 963, February 27, 1975. Washington: U.S. Govt. Print. Off.^ FDA (September 26, 1973). "Diethylstilbestrol. Use as postcoital contraceptive; patient labeling". Fed Regist. 38 (186): 26809–11.^ a b FDA (February 26, 1975). "Estrogens for oral or parenteral use. Drugs for human use; drug efficacy study; amended notice". Fed Regist. 40 (39): 8242.^ FDA (September 26, 1973). "Certain estrogens for oral use. Notice of withdrawal of approval of new drug applications". Fed Regist. 38 (186): 26824–6.^ a b Dutton, Diana B. (1988). Worse than the disease: pitfalls of medical progress. Cambridge: Cambridge University Press. ISBN 978-0-521-34023-6.^ FDA (February 5, 1975). "Diethylstilbestrol as postcoital oral contraceptive; patient labeling". Fed Regist. 40 (25): 5351–5.^ FDA (February 5, 1975). "Certain estrogens for oral use or parenteral use. Drugs for human use; drug efficacy study implementation; follow-up notice". Fed Regist. 40 (25): 5384.^ FDA (March–April 1978). "DES and Breast Cancer". FDA Drug Bull. 8 (2): 10.^ Hatcher, Robert A.; Stewart, Gary K.; Stewart, Felicia; Guest, Felicia; Schwartz, David W.; Jones, Stephanie A. (1980). Contraceptive Technology 1980–1981 (10th
Add Comment